Found 16 matching trials
Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in the Preservation of the Tooth Socket PHASE2 Twenty patients referring to periodontics department of Boroujerd Azad univ...
Show More Location
Amirhossein Farahmand
Learn More & Join Trial
The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss PHASE4 High bone turnover with the bone resorption exceeding bone formation is a m...
Show More Location
Multiple Locations
Learn More & Join Trial
Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis PHASE4 Increased bone formation in the absence of accelerated resorption is result...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover PHASE4 Osteoporosis affects 24.5% of women over 65 and results in fracture-related...
Show More Status
Active Not Recruiting
Location
University of Kentucky
Learn More & Join Trial
Bisphosphonate Therapy for Osteogenesis Imperfecta PHASE4 The study is designed to evaluate the efficacy and safety of "Bisphosphonat...
Show More Location
Multiple Locations
Learn More & Join Trial
The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover PHASE2 It is hypothesized that effervescent alendronate will be able to maintain b...
Show More Location
Ghent University Hospital
Learn More & Join Trial
Stem Cell Recruitment in Osteoporosis Therapy NA Osteoporosis is an important health problem in the rapidly-aging demographi...
Show More Location
Johns Hopkins Bayview Medical Center
Learn More & Join Trial
Cyclic Versus Daily Teriparatide on Bone Mass PHASE2 Osteoporosis is a disease that affects millions of individuals in the Unite...
Show More Location
Helen Hayes Hospital
Learn More & Join Trial
Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis PHASE3 The purpose of this study is to provide 24 months of standard of care data ...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis PHASE3 Osteoporosis is a condition in which the amount of bone is reduced, the bon...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Learn More & Join Trial